Emerging Risks: Methodology, Classification and Policy Implications
نویسندگان
چکیده
منابع مشابه
Health policy implications of emerging infections.
The solutions to emerging disease problems involve politics and policy issues, as well as solid science. The National Academy of Sciences’ Institute of Medicine (IOM), whose mission is to “improve the health of people of the nation and the world,” draws upon the expertise of elected members as well as others in the United States and other nations to make policy recommendations. Groups convene t...
متن کاملE-Cigarettes: Use, Effects on Smoking, Risks, and Policy Implications.
Since e-cigarettes appeared in the mid-2000s, some practitioners, researchers, and policy makers have embraced them as a safer alternative to conventional cigarettes and an effective way to stop smoking. While e-cigarettes deliver lower levels of carcinogens than do conventional cigarettes, they still expose users to high levels of ultrafine particles and other toxins that may substantially inc...
متن کاملEmerging Leadership Models: Implications for Public Policy Education
Judy Lawrence Rogers Miami University "It's all a question of story. We are in trouble just now because we do not have a good story. We are in-between stories. The Old Story the account of how the world came to be and how we fit into it is not functioning properly, and we have not learned the New Story. The Old Story sustained us for long periods of time. It shaped our emotional attitudes, prov...
متن کاملEmerging and re-emerging viral diseases: risks and controls
In the present globalized world with overflowing travels and trades, human health has been increasingly threatened due to incidences of emerging or/and re-emerging infectious diseases. The most important sources of novel human pathogens are mainly farm mammals and poultry, and to some extent, wild animals and arthropods. It is estimated that zoonosis constitute about 60% of the ‘known’, and up ...
متن کاملEmerging molecular classification in RCC: implications for drug development
In the past decade, progress has been made in the development of targeted therapies for advanced renal cell carcinoma. However, as multiple therapeutic choices become available for clinicians, we currently lack effective indicators to allow physicians to choose the best treatment option for specific patients. For approved targeted therapies, potential molecules that could indicate drug effectiv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Risk Analysis and Crisis Response
سال: 2014
ISSN: 2210-8505
DOI: 10.2991/jrarc.2014.4.3.1